This study found that high-dose HLD protected mice colonic tissues with DSS-induced colitis, as evidenced by reduced DAI and colonic histological scores, reduced NF-κB pathway-related inflammatory cytokines in mouse serum, and reduced NF-κB p65 levels in colonic tissues. The gene discussed is NFKB1; the disease is colitis.